159 related articles for article (PubMed ID: 3527077)
1. Cutaneous insulin reaction resembling acanthosis nigricans.
Fleming MG; Simon SI
Arch Dermatol; 1986 Sep; 122(9):1054-6. PubMed ID: 3527077
[TBL] [Abstract][Full Text] [Related]
2. Acanthosis nigricans as a local cutaneous side effect of repeated human insulin injections.
Buzási K; Sápi Z; Jermendy G
Diabetes Res Clin Pract; 2011 Nov; 94(2):e34-6. PubMed ID: 21839533
[TBL] [Abstract][Full Text] [Related]
3. Exogenous insulin-derived acanthosis nigricans: could it be a cause of increased insulin requirement?
Dhingra M; Garg G; Gupta M; Khurana U; Thami GP
Dermatol Online J; 2013 Jan; 19(1):9. PubMed ID: 23374951
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous amyloidosis and insulin with coexistence of acanthosis nigricans.
Nandeesh BN; Rajalakshmi T; Shubha B
Indian J Pathol Microbiol; 2014; 57(1):127-9. PubMed ID: 24739851
[TBL] [Abstract][Full Text] [Related]
5. Case report: acanthosis nigricans resulting from repetitive same-site insulin injections.
Brodell JD; Cannella JD; Helms SE
J Drugs Dermatol; 2012 Dec; 11(12):e85-7. PubMed ID: 23377528
[TBL] [Abstract][Full Text] [Related]
6. Case of exogenous insulin-derived acanthosis nigricans caused by insulin injections.
Yahagi E; Mabuchi T; Nuruki H; Manabe Y; Ikoma N; Ozawa A; Yamamoto N; Tanaka E; Sekido Y; Matsuyama T
Tokai J Exp Clin Med; 2014 Mar; 39(1):5-9. PubMed ID: 24733591
[TBL] [Abstract][Full Text] [Related]
7. Acanthosis nigricans-like hyperpigmentation secondary to triazinate therapy.
Greenspan AH; Shupack JL; Foo SH; Wise AC
Arch Dermatol; 1985 Feb; 121(2):232-5. PubMed ID: 3977338
[TBL] [Abstract][Full Text] [Related]
8. Exogenous insulin-derived Acanthosis nigricans.
Mailler-Savage EA; Adams BB
Arch Dermatol; 2008 Jan; 144(1):126-7. PubMed ID: 18209191
[No Abstract] [Full Text] [Related]
9. Coexistence of insulin-derived amyloidosis and an overlying acanthosis nigricans-like lesion at the site of insulin injection.
Kudo-Watanuki S; Kurihara E; Yamamoto K; Mukai K; Chen KR
Clin Exp Dermatol; 2013 Jan; 38(1):25-9. PubMed ID: 22924529
[TBL] [Abstract][Full Text] [Related]
10. Endocrine profiles in six patients with acanthosis nigricans.
Kapasi A; Varthakavi PK; Khopkar U; Wadhwa SL; Nihalani KD
J Assoc Physicians India; 1994 Jul; 42(7):529-30. PubMed ID: 7868520
[TBL] [Abstract][Full Text] [Related]
11. [Pseudo-Acanthosis nigricans in a 12 year old boy after kidney transplantation].
von Schnakenburg C; Enke B; Jürgens K; Offner G
Klin Padiatr; 2001; 213(5):288-9. PubMed ID: 11582528
[TBL] [Abstract][Full Text] [Related]
12. Oral acanthosis nigricans in chronic hepatitis B with a 21-year follow up.
Chrysomali E; Piperi E; Sklavounou-Andrikopoulou A
J Dermatol; 2011 Dec; 38(12):1172-6. PubMed ID: 21966946
[TBL] [Abstract][Full Text] [Related]
13. Juvenile acanthosis nigricans.
Sinha S; Schwartz RA
J Am Acad Dermatol; 2007 Sep; 57(3):502-8. PubMed ID: 17592743
[TBL] [Abstract][Full Text] [Related]
14. [Relations between acanthosis nigricans benigna and pseudoacanthosis nigricans].
Lang E; Schmidt R
Hautarzt; 1982 Dec; 33(12):640-5. PubMed ID: 7161102
[TBL] [Abstract][Full Text] [Related]
15. Acanthosis nigricans at sites of insulin injection in a man with diabetes.
Huang Y; Hessami-Booshehri M
CMAJ; 2018 Nov; 190(47):E1390. PubMed ID: 30478218
[No Abstract] [Full Text] [Related]
16. [Will acanthosis nigricans be a new cutaneous manifestation of human immunodeficiency virus infection?].
Maltez F; Martins T; Morgado A; Proença R
Acta Med Port; 1997; 10(6-7):493-5. PubMed ID: 9341043
[TBL] [Abstract][Full Text] [Related]
17. Human recombinant insulin and amyloidosis: an unexpected association.
Sie MP; van der Wiel HE; Smedts FM; de Boer AC
Neth J Med; 2010 Mar; 68(3):138-40. PubMed ID: 20308712
[TBL] [Abstract][Full Text] [Related]
18. [On the difficulty of differentiation of malignant and benign acanthosis nigricans].
Bernhardt E
Przegl Dermatol; 1968; 55(6):769-73. PubMed ID: 5709701
[No Abstract] [Full Text] [Related]
19. [Malignant form of papillary-pigmented skin dystrophy (acanthosis nigricans malignum)].
Shupen'ko NM; Svirid AA
Vestn Dermatol Venerol; 1980 Feb; (2):37-40. PubMed ID: 7355624
[No Abstract] [Full Text] [Related]
20. Acanthosis nigricans--an uncommon cutaneous adverse effect of a common medication: report of two cases.
Sawatkar GU; Dogra S; Bhadada SK; Kanwar AJ
Indian J Dermatol Venereol Leprol; 2013; 79(4):553. PubMed ID: 23760338
[No Abstract] [Full Text] [Related]
[Next] [New Search]
